Home › Companies › Core Laboratories Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Core Laboratories Inc.’s Form 8-K, filed 2026-05-13 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Core Laboratories Inc. in the interactive database Compare manager voting policies
These tallies are Core Laboratories Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Harvey Klingensmith | 35,880,017 | -- | -- | 3,756,385 | 2,077,874 | Majority: yes |
| Elect Director: Curtis Anastasio | 39,271,486 | -- | -- | 364,916 | 2,077,874 | Majority: yes |
| Proposal 2: Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, 2026 was approved as follows: | 41,220,974 | 484,159 | 9,143 | -- | -- | Majority: yes |
| Proposal 3: Approving the Compensation of the Company's Named Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows: | 38,265,683 | 1,263,224 | 107,495 | -- | 2,077,874 | Majority: yes |
Source: Core Laboratories Inc., Form 8-K, filed with the SEC on 2026-05-13 — read the filing on EDGAR.
Each item below shows how the 249 asset managers that disclosed a Core Laboratories Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Core Laboratories Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 12 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Core Laboratories Inc.’s own tally for this item (“Proposal 3: Approving the Compensation of the Company's Named Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows:”): 38,265,683 for, 1,263,224 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,096,682 outstanding shares: 83% for, 3% against (86% of the company cast a for/against vote).
The 248 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARIEL INVESTMENT TRUST | 6,829,935 | 0 | 0 | 0 | For |
| BlackRock | 4,408,531 | 0 | 0 | 0 | For |
| ARIEL INVESTMENTS, LLC | 4,380,721 | 0 | 0 | 0 | For |
| DISCIPLINED GROWTH INVESTORS INC /MN | 4,104,567 | 0 | 0 | 0 | For |
| Vanguard | 3,670,101 | 6 | 0 | 0 | For |
| EARNEST PARTNERS LLC | 2,107,048 | 0 | 0 | 0 | For |
| State Street | 1,463,880 | 1,634 | 0 | 0 | For |
| Charles Schwab | 1,415,357 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,190,717 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 1,124,050 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,056,467 | 0 | 0 | 0 | For |
| Fidelity | 997,003 | 0 | 0 | 0 | For |
| American Century | 0 | 894,134 | 0 | 0 | Against |
| GENDELL JEFFREY L | 648,460 | 0 | 0 | 0 | For |
| Treasurer of the State of North Carolina | 582,550 | 0 | 0 | 0 | For |
| Northern Trust | 564,839 | 0 | 0 | 0 | For |
| Goldman Sachs | 536,914 | 0 | 0 | 0 | For |
| Dimensional | 365,178 | 0 | 0 | 0 | For |
| Elevation Series Trust | 360,263 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 311,697 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 273,757 | 0 | 0 | 0 | For |
| Russell Investments | 266,865 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 205,036 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 184,762 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 174,316 | 0 | 0 | 0 | For |
Showing the 25 largest of 248 asset managers. See all 248 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Core Laboratories Inc.’s own tally for this item (“Elect Director: Curtis Anastasio”): 39,271,486 for, 364,916 withheld, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,096,682 outstanding shares: 85% for, 0.8% withheld (86% of the company cast a for/withheld vote).
The 70 asset managers below cast 100% of the shares they voted on this item FOR (20,363,977 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARIEL INVESTMENT TRUST | 6,829,935 | 0 | 0 | 0 | For |
| BlackRock | 3,719,096 | 0 | 0 | 0 | For |
| Vanguard | 3,314,318 | 0 | 2 | 0 | For |
| HARBOR FUNDS | 1,124,050 | 0 | 0 | 0 | For |
| Fidelity | 991,044 | 0 | 0 | 0 | For |
| State Street | 688,535 | 0 | 0 | 0 | For |
| Charles Schwab | 675,301 | 0 | 0 | 0 | For |
| American Century | 447,061 | 0 | 0 | 0 | For |
| Elevation Series Trust | 360,263 | 0 | 0 | 0 | For |
| Goldman Sachs | 295,045 | 0 | 0 | 0 | For |
| Dimensional | 287,417 | 0 | 0 | 0 | For |
| Royce | 172,173 | 0 | 0 | 0 | For |
| WisdomTree | 142,128 | 0 | 0 | 0 | For |
| Russell Investments | 122,799 | 0 | 0 | 0 | For |
| TIAA | 98,430 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 88,941 | 0 | 0 | 0 | For |
| Jackson National | 85,293 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 75,988 | 0 | 0 | 0 | For |
| Equitable | 46,405 | 0 | 29,250 | 0 | For |
| ETF Opportunities Trust | 71,201 | 0 | 0 | 0 | For |
| Principal | 67,151 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 64,295 | 0 | 0 | 0 | For |
| Empower | 47,486 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 46,877 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 45,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.
Combines 4 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Core Laboratories Inc.’s own tally for this item (“Elect Director: Harvey Klingensmith”): 35,880,017 for, 3,756,385 withheld, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,096,682 outstanding shares: 78% for, 8% withheld (86% of the company cast a for/withheld vote).
The 70 asset managers below cast 100% of the shares they voted on this item FOR (20,085,274 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARIEL INVESTMENT TRUST | 6,829,935 | 0 | 0 | 0 | For |
| BlackRock | 3,719,096 | 0 | 0 | 0 | For |
| Vanguard | 3,294,706 | 0 | 19,613 | 0 | For |
| HARBOR FUNDS | 1,124,050 | 0 | 0 | 0 | For |
| Fidelity | 991,044 | 0 | 0 | 0 | For |
| State Street | 687,705 | 0 | 830 | 0 | For |
| Charles Schwab | 675,301 | 0 | 0 | 0 | For |
| American Century | 447,061 | 0 | 0 | 0 | For |
| Elevation Series Trust | 360,263 | 0 | 0 | 0 | For |
| Goldman Sachs | 295,045 | 0 | 0 | 0 | For |
| Dimensional | 287,417 | 0 | 0 | 0 | For |
| Royce | 172,173 | 0 | 0 | 0 | For |
| WisdomTree | 142,128 | 0 | 0 | 0 | For |
| Russell Investments | 0 | 0 | 122,799 | 0 | Abstain |
| TIAA | 98,430 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 88,941 | 0 | 0 | 0 | For |
| Jackson National | 85,293 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 75,988 | 0 | 0 | 0 | For |
| Equitable | 46,405 | 0 | 29,250 | 0 | For |
| ETF Opportunities Trust | 71,201 | 0 | 0 | 0 | For |
| Principal | 67,151 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 64,295 | 0 | 0 | 0 | For |
| Empower | 47,486 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 0 | 0 | 46,877 | 0 | Abstain |
| HOTCHKIS & WILEY FUNDS /DE/ | 45,400 | 0 | 0 | 0 | For |
Showing the 25 largest of 70 asset managers. See all 70 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Core Laboratories Inc.’s own tally for this item (“Proposal 2: Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, ”): 41,220,974 for, 484,159 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,096,682 outstanding shares: 89% for, 1% against (90% of the company cast a for/against vote).
The 68 asset managers below cast 99.8% of the shares they voted on this item FOR (20,320,018 for, 24,025 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ARIEL INVESTMENT TRUST | 6,829,935 | 0 | 0 | 0 | For |
| BlackRock | 3,719,096 | 0 | 0 | 0 | For |
| Vanguard | 3,314,316 | 4 | 0 | 0 | For |
| HARBOR FUNDS | 1,124,050 | 0 | 0 | 0 | For |
| Fidelity | 991,044 | 0 | 0 | 0 | For |
| State Street | 688,500 | 35 | 0 | 0 | For |
| Charles Schwab | 675,301 | 0 | 0 | 0 | For |
| American Century | 447,061 | 0 | 0 | 0 | For |
| Elevation Series Trust | 360,263 | 0 | 0 | 0 | For |
| Goldman Sachs | 295,045 | 0 | 0 | 0 | For |
| Dimensional | 287,417 | 0 | 0 | 0 | For |
| Royce | 172,173 | 0 | 0 | 0 | For |
| WisdomTree | 142,128 | 0 | 0 | 0 | For |
| Russell Investments | 122,799 | 0 | 0 | 0 | For |
| TIAA | 98,430 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 88,941 | 0 | 0 | 0 | For |
| Jackson National | 85,293 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 75,988 | 0 | 0 | 0 | For |
| Equitable | 75,655 | 0 | 0 | 0 | For |
| ETF Opportunities Trust | 71,201 | 0 | 0 | 0 | For |
| Principal | 67,151 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 64,295 | 0 | 0 | 0 | For |
| VanEck ETF Trust | 46,877 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 45,400 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 45,190 | 0 | 0 | 0 | For |
Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.
99% Majority: yes · of votes cast
Core Laboratories Inc.’s own tally for this item (“Proposal 2: Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, ”): 41,220,974 for, 484,159 against, per its Form 8-K filed 2026-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,096,682 outstanding shares: 89% for, 1% against (90% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (49,186 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 47,486 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 1,700 | 0 | 0 | 0 | For |
Ranked by the number of Core Laboratories Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 46,096,682 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ARIEL INVESTMENT TRUST | 14.82% |
| 2 | BlackRock | 9.56% |
| 3 | ARIEL INVESTMENTS, LLC | 9.50% |
| 4 | DISCIPLINED GROWTH INVESTORS INC /MN | 8.90% |
| 5 | Vanguard | 7.96% |
| 6 | EARNEST PARTNERS LLC | 4.57% |
| 7 | State Street | 3.18% |
| 8 | Charles Schwab | 3.07% |
| 9 | T. Rowe Price | 2.58% |
| 10 | HARBOR FUNDS | 2.44% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Ariel Investments, LLC | 30.53% | 13G |
| BlackRock | 15.64% | 13F |
| EARNEST PARTNERS LLC | 6.99% | 13G |
| Vanguard Group | 6.68% | 13F |
| DISCIPLINED GROWTH INVESTORS INC /MN | 6.60% | 13G |
| State Street | 4.47% | 13F |
| Dimensional Fund Advisors | 2.93% | 13F |
| Geode Capital | 2.47% | 13F |
| Goldman Sachs | 1.84% | 13F |
| Charles Schwab | 1.49% | 13F |
Percentages above are of 46,096,682 shares outstanding, as reported by Core Laboratories Inc. on its Form 10-Q dated 2026-04-24 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Core Laboratories Inc.’s 10-Q dated 2026-04-24. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Core Laboratories Inc.'s shareholder meeting held 2026-05-12, in the 2025-2026 proxy season, 249 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,192 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation philosophy, policies and procedures… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Core Laboratories Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-13.
Core Laboratories Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).